KORU Medical Systems Inc.

04/03/2026 | Press release | Distributed by Public on 04/03/2026 14:01

Material Agreement, Financial Obligation (Form 8-K)

ITEM 1.01 ENTRY INTO A MATERIAL DEFINITIVE AGREEMENT.

Reference is made to the disclosure under Item 2.03 below which is hereby incorporated in this Item 1.01 by reference.

ITEM 2.03 CREATION OF A DIRECT FINANCIAL OBLIGATION OR AN OBLIGATION UNDER AN OFF-BALANCE SHEET ARRANGEMENT OF A REGISTRANT.

On March 30, 2026, KORU Medical Systems, Inc. (the "Company") entered into an amendment (the "Amendment") to its loan and security agreement, by and between the Company and HSBC Ventures USA Inc., as lender, dated March 8, 2024, as amended (the "Loan and Security Agreement"), relating to a revolving credit facility in an aggregate principal amount not to exceed $5,000,000 (the "Revolver") and a term loan facility in an aggregate principal amount not to exceed $5,000,000 (the "Term Loan" and collectively with the Revolver, the "Credit Facility"). The Company has not drawn on the Credit Facility, and there is no obligation for the Company to do so at any time.

The Amendment extends the maturity of the $5,000,000 Revolver from December 31, 2026 to March 30, 2028, and extends the interest-only period of the $5,000,000 Term Loan from September 30, 2026 to June 30, 2027 with a possible further extension to December 31, 2027 upon the achievement of certain EBITDA milestones as set forth therein. The Term Loan maturity has been extended from December 1, 2028 to December 1, 2029. The Amendment lowers the interest rate floor to 5.50% from 6.50% for the Revolver and the Term Loan. The Amendment removes the adjusted quick ratio covenant for both the Term Loan and the Revolver. The adjusted quick ratio covenant for the Revolver has been replaced with a remaining months liquidity covenant of at least twelve months, to be tested monthly beginning the first month the Revolver is drawn on; provided, however, the Company will be in compliance if trailing three (3) month average Adjusted EBITDA (as defined in the Revolver) is positive.

The foregoing description of the Amendment is qualified in its entirety by reference to the full text of the Amendment attached as Exhibit 10.1 to this Current Report on Form 8-K, which is incorporated by reference into this Item 1.01.

KORU Medical Systems Inc. published this content on April 03, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on April 03, 2026 at 20:01 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]